المؤلفون: Gondrie IPE; From the *Department of Pediatrics, Division of Infectious Diseases and Immunology, Erasmus MC University Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands; †Department of Pharmacy, and ‡Laboratory of Pediatric Infectious Diseases, Department of Pediatrics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands; and §Department of Pediatrics, Franciscus Hospital, Rotterdam, The Netherlands., Bastiaans DET, Fraaij PLA, Driessen GJA, van der Knaap LC, Visser EG, van Jaarsveld P, de Groot R, Hartwig NG, Burger DM, van Rossum AMC

المصدر: The Pediatric infectious disease journal [Pediatr Infect Dis J] 2017 Oct; Vol. 36 (10), pp. 976-980.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Williams & Wilkins Country of Publication: United States NLM ID: 8701858 Publication Model: Print Cited Medium: Internet ISSN: 1532-0987 (Electronic) Linking ISSN: 08913668 NLM ISO Abbreviation: Pediatr Infect Dis J Subsets: MEDLINE

مواضيع طبية MeSH: Anti-HIV Agents/*therapeutic use , HIV Infections/*drug therapy , HIV Infections/*virology , Lopinavir/*therapeutic use , Ritonavir/*therapeutic use, Adolescent ; Anti-HIV Agents/administration & dosage ; Anti-HIV Agents/adverse effects ; Child ; Child, Preschool ; Female ; Follow-Up Studies ; HIV-1 ; Humans ; Infant ; Kaplan-Meier Estimate ; Lopinavir/administration & dosage ; Lopinavir/adverse effects ; Male ; Ritonavir/administration & dosage ; Ritonavir/adverse effects ; Sustained Virologic Response ; Viral Load